Press release
Uveitis Industry is Expected to Reach $837 Million by 2031 - Novartis Inc., AbbVie, Johnson & Johnson Services Inc., Amgen
Uveitis Market || 2024-2031
Uveitis is an inflammation of the eye's middle layer, commonly affecting individuals aged 20 to 50. It can be a serious condition, potentially leading to vision loss.
Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/uveitis-market
Market Trends:
The uveitis market is driven by technological advancements, a growing elderly population, and increased investment in research and development. Rising cases of ophthalmic disorders, such as uveitis glaucoma, and cataracts, along with improved medical infrastructure, fuel market growth. The adoption of uveitis medications, including eye drops, injections, and implants, is expanding due to government initiatives and innovative product launches. For example, Alimera Sciences received reimbursement for its ILUVIEN implant for non-infectious uveitis, contributing to the market's expansion.
Segment Covered in the Microplate Systems Market:
By Uveitis Type: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Pan Uveitis
By Medications: Corticosteroids, Anti-Rheumatic Drugs, Cycloplegic-Mydriatic Drugs, Immunomodulatory Therapy, Biological Therapy, Anti-Viral Drugs, Others
By Medication Form: Eye Drops, Pills, Injections, Implants), By End-User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Analysis:
The global Uveitis Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
The global Uveitis Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Uveitis Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
Major Key Players:
• Novartis AG
• AbbVie
• Johnson & Johnson Services, Inc.
• Amgen
• Alimera Sciences
• Bausch & Lomb Incorporated.
• Kiora Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
• EyePoint Pharmaceuticals, Inc.
• Clearside Biomedical
Product Portfolio
Durezol is a topical corticosteroid used to treat pain and inflammation associated with ocular surgery and endogenous anterior uveitis.
Get Customization in the report as per your requierments: https://www.datamintelligence.com/customize/uveitis-market
Related Reports
Trauma Fixation Devices Market: https://www.datamintelligence.com/research-report/trauma-fixation-devices-market
Cardiac Ablation Devices Market: https://www.datamintelligence.com/research-report/cardiac-ablation-devices-market
Thyroid Ablation Devices Market: https://www.datamintelligence.com/research-report/thyroid-ablation-devices-market
Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Uveitis Industry is Expected to Reach $837 Million by 2031 - Novartis Inc., AbbVie, Johnson & Johnson Services Inc., Amgen here
News-ID: 3648004 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
AI in Logistics Market to Surge to USD 306.76 Billion by 2032, Growing at an Ext …
Leander, Texas and Tokyo, Japan - Dec 08, 2025
According to DataM Intelligence, the Global AI in Logistics Market reached US$ 15.28 billion in 2024 and is projected to reach US$ 306.76 billion by 2032, expanding at a compound annual growth rate (CAGR) of 42% during the forecast period 2025-2032. Key growth drivers include the critical need for supply chain resilience and transparency, soaring demand for warehouse automation to combat labor…
Platform as a Service Market to Skyrocket to USD 445.54 Billion by 2032, Growing …
Leander, Texas and Tokyo, Japan - Dec 07, 2025
According to DataM Intelligence, the Global Platform as a Service (PaaS) Market reached US$ 88.96 billion in 2024 and is projected to reach US$ 445.54 billion by 2032, expanding at a compound annual growth rate (CAGR) of 22.31% during the forecast period 2025-2032. Key growth drivers include the accelerating pace of digital transformation across all industries, the shift to cloud-native application development,…
High Performance Adhesives Market Poised for 6.32% CAGR Growth to 2031 | Driven …
Leander, Texas and Tokyo, Japan - Dec 07, 2025
According to DataM Intelligence, the Global High-Performance Adhesives Market is expected to expand at a compound annual growth rate (CAGR) of 6.32% during the forecast period (2024-2031). Key growth drivers include the demand for lightweight materials and innovative bonding solutions in electric vehicles and aerospace, the increasing miniaturisation and complexity of electronic devices requiring precise adhesives, stringent regulatory standards for safety and…
Parkinson's Disease Therapeutics Market to Reach USD 12.83 Billion by 2033, Grow …
Leander, Texas and Tokyo, Japan - Dec 07, 2024
According to DataM Intelligence, the Global Parkinson's Disease Therapeutics Market reached US$ 5.92 Billion in 2024 and is projected to reach US$ 12.83 Billion by 2033, expanding at a compound annual growth rate (CAGR) of 8.1% during the forecast period 2025-2033. Key growth drivers include the rising prevalence of Parkinson's disease associated with an aging global population, the introduction of novel drug…
More Releases for Uveitis
Uveitis Market : An Overview Report
Introduction:
Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis…
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of…
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based…
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview
Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures.
Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html
As per Cochrane,…
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).
According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &…
